Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial.
Nat Commun. 2023 Jan 19;14(1):331. doi: 10.1038/s41467-022-35768-3.
Nat Commun. 2023.
PMID: 36658109
Free PMC article.
All markers are inversely associated with COVID-19 risk and directly associated with vaccine efficacy. In vaccine recipients with nAb ID50 titers of 50, 100, and 7230 international units (IU50)/ml, vaccine efficacy estimates are 75.7% (49.8%, 93.2%), 81.7% (6 …
All markers are inversely associated with COVID-19 risk and directly associated with vaccine efficacy. In vaccine recipients w …
Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial.
Fong Y, Huang Y, Benkeser D, Carpp LN, Áñez G, Woo W, McGarry A, Dunkle LM, Cho I, Houchens CR, Martins K, Jayashankar L, Castellino F, Petropoulos CJ, Leith A, Haugaard D, Webb B, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Randhawa AK, Andrasik MP, Kublin JG, Hutter J, Keshtkar-Jahromi M, Beresnev TH, Corey L, Neuzil KM, Follmann D, Ake JA, Gay CL, Kotloff KL, Koup RA, Donis RO, Gilbert PB; Immune Assays Team; Coronavirus Vaccine Prevention Network (CoVPN)/2019nCoV-301 Principal Investigators and Study Team; United States Government (USG)/CoVPN Biostatistics Team.
Fong Y, et al.
Nat Commun. 2023 Mar 22;14(1):1581. doi: 10.1038/s41467-023-37367-2.
Nat Commun. 2023.
PMID: 36949083
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite